Key Findings:  This rat model of inflammatory bowel disease (IBD) found that tetrahydrocannabinol (THC) exacerbates the negative behavioral effects of IBD
Type of Study:  Animal Study
Study Result:  Negative
Study Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied:  Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype I